Conditions: Sexual Dysfunctions, Psychological
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 596
Healthy volunteers: no

Brief summary:
To generate additional long-term safety and efficacy data on flibanserin in premenopausal women and establish long-term safety and tolerability of flibanserin in naturally postmenopausal women with Hypoactive Sexual Desire Disorder who have completed a prior clinical trial of flibanserin (Trial 511.130, 511.147, or 511.156).

Detailed description:

Arms:
arm 1: flibanserin 100mg po qd

Interventions: intervention 1: flibanserin
Intervention descriptions: intervention 1: all patients will receive open-label flibanserin 100mg

Protocol document: